Location History:
- Manukau, NZ (2012)
- Papatoetoe Manukau, NZ (2016)
Company Filing History:
Years Active: 2012-2016
Title: Innovations by Zaheer Khan in Nucleic Acid Technologies
Introduction
Zaheer Khan is an accomplished inventor based in Papatoetoe Manukau, New Zealand. He has made significant contributions to the field of molecular biology, particularly in the generation and detection of nucleic acid molecules. With a total of two patents to his name, his work has implications for both diagnostic and therapeutic applications.
Latest Patents
Zaheer Khan's latest patents include innovative methods for generating single-stranded nucleic acid molecules. The first patent focuses on enhancing solid-phase polynucleotide amplification through the use of specially designed primers. This invention allows for improved participation of solid support primers relative to aqueous phase primers, thereby increasing the efficiency of nucleic acid generation. Additionally, the patent provides methods for labeling solid matrices with nucleic acid molecules, along with kits for conducting amplification reactions.
The second patent involves the development of oligonucleotide amplification primers specifically targeting oncogenic HPV. This invention is crucial for diagnostic and detection assays, providing methods and reagents, including biochips, to detect and distinguish between various analytes in a sample. These advancements highlight Zaheer Khan's commitment to improving diagnostic technologies in the medical field.
Career Highlights
Zaheer Khan is currently associated with Genera Biosystems Limited, where he continues to innovate in the field of molecular diagnostics. His work has garnered attention for its potential to enhance the accuracy and efficiency of nucleic acid testing.
Collaborations
Zaheer collaborates with notable colleagues, including Daniel Jonathan Park and Karl Frederick Poetter. Their combined expertise contributes to the advancement of technologies in the field of molecular biology.
Conclusion
Zaheer Khan's contributions to nucleic acid technologies demonstrate his innovative spirit and dedication to improving diagnostic methods. His patents reflect a significant advancement in the field, paving the way for future developments in molecular diagnostics.